Search research articles
Contact Us
Filters
Showing results (241-250 of 436) with videos related to
Page
of 44
Sort By:
Journal of the American College of Cardiology
|
November 28, 2009
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures
Richard C Becker, James Scheiman, Harold L Dauerman, et al.
Journal of the American College of Cardiology
|
March 3, 2012
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease
Tracy Y Wang, Dominick J Angiolillo, Mary Cushman, et al.
European Heart Journal
|
September 30, 2015
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
Emil Hagström, Stefan K James, Maria Bertilsson, et al.
Lancet (London, England)
|
August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin, Stefan James, Robert F Storey, et al.
Circulation
|
May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications
Robert O Bonow, William E Mitch, Richard W Nesto, et al.
Platelets
|
June 2, 2021
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy
Thomas A Nelson, William A E Parker, Tatevik Ghukasyan Lakic, et al.
American Heart Journal
|
January 25, 2008
Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry
Tracy Y Wang, Lee A Robinson, Fang-Shu Ou, et al.
The American Journal of Cardiology
|
July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin
E Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
Archives of Internal Medicine
|
October 27, 2004
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction
Frederick A Spencer, Gregg C Fonarow, Paul D Frederick, et al.
Clinical Chemistry
|
May 24, 2013
Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study
Axel Åkerblom, Lars Wallentin, Anders Larsson, et al.
Page
of 44
Search research articles
Search
Showing results (241-250 of 436) with videos related to
Sort By:
Page
of 44
Journal of the American College of Cardiology
|
November 28, 2009
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures
Richard C Becker, James Scheiman, Harold L Dauerman, et al.
Journal of the American College of Cardiology
|
March 3, 2012
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease
Tracy Y Wang, Dominick J Angiolillo, Mary Cushman, et al.
European Heart Journal
|
September 30, 2015
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
Emil Hagström, Stefan K James, Maria Bertilsson, et al.
Lancet (London, England)
|
August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin, Stefan James, Robert F Storey, et al.
Circulation
|
May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications
Robert O Bonow, William E Mitch, Richard W Nesto, et al.
Platelets
|
June 2, 2021
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy
Thomas A Nelson, William A E Parker, Tatevik Ghukasyan Lakic, et al.
American Heart Journal
|
January 25, 2008
Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry
Tracy Y Wang, Lee A Robinson, Fang-Shu Ou, et al.
The American Journal of Cardiology
|
July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin
E Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
Archives of Internal Medicine
|
October 27, 2004
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction
Frederick A Spencer, Gregg C Fonarow, Paul D Frederick, et al.
Clinical Chemistry
|
May 24, 2013
Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study
Axel Åkerblom, Lars Wallentin, Anders Larsson, et al.
Page
of 44